| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/29/2010 | US20100190770 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | US20100190762 Triazolyl phenyl benzenesulfonamides |
| 07/29/2010 | US20100190749 Benzoxazole kinase inhibitors and methods of use |
| 07/29/2010 | US20100190747 Fused ring compound and use thereof |
| 07/29/2010 | US20100190746 Quinazolinones as potassium channel modulators |
| 07/29/2010 | US20100190688 Tetrapeptide analogs |
| 07/29/2010 | US20100190687 Pyrimidinone derivatives and methods of use thereof |
| 07/29/2010 | US20100189773 5-cyano-4- (pyrrolo [2,3] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/29/2010 | US20100187977 Compound for use in organic electroluminescent device and organic electroluminescent device |
| 07/29/2010 | US20100187519 Material for organic electroluminescent element, and organic electroluminescent element |
| 07/29/2010 | US20100187515 Use of a Precursor of an N-Dopant for Doping an Organic Semiconductive Material, Precursor and Electronic or Optoelectronic Component |
| 07/29/2010 | CA2750449A1 New adenosine receptor ligands and uses thereof |
| 07/29/2010 | CA2749970A1 Novel heterocyclic compounds as metap-2 inhibitors |
| 07/29/2010 | CA2749055A1 Antiviral agents |
| 07/29/2010 | CA2748864A1 Amino-heterocyclic compounds used as pde9 inhibitors |
| 07/28/2010 | EP2210891A1 New adenosine receptor ligands and uses thereof |
| 07/28/2010 | EP2209789A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 07/28/2010 | EP2209788A2 Pyrrolopyrrole derivatives, their manufacture and use |
| 07/28/2010 | EP2209784A1 Compounds for the treatment of hepatitis c |
| 07/28/2010 | EP2209775A1 Heterobicyclic compounds as histamine h4-receptor antagonists |
| 07/28/2010 | EP2209375A1 Parp inhibitor compounds, compositions and methods of use |
| 07/28/2010 | EP2016080B1 Dihydropyrazolopyrimidinone derivatives |
| 07/28/2010 | EP1633746B1 New indole derivatives as factor xa inhibitors |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | CN101790533A cyclopropyl fused indolobenzazepine hcv inhibitors |
| 07/28/2010 | CN101790525A pharmaceutical compounds |
| 07/28/2010 | CN101790524A 抗病毒化合物 Antiviral compounds |
| 07/28/2010 | CN101121717B Synthesis for natural medicament physostigmine for resisting senile dementia disease and phenylaminoformic acid ester phenserine |
| 07/27/2010 | US7763725 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists and antagonists of melanocortin receptors |
| 07/27/2010 | US7763624 protein tyrosine kinase inhibitorssuch as 1-(but-3-enyl)-N3-(2,6-dimethylphenyl)-N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine, used for the treatment of autoimmune diseases and as antiproliferative or anticarcinogenic agents |
| 07/27/2010 | US7763622 such as 5-methyl-6-(2-chloro-4-fluorophenyl)-7-(4-methylpiperidin-1-yl)-[1,2,4]-triazolo[1,5-a]pyrimidine, used for controlling phytopathogenic fungi; improved fungicidal activity |
| 07/27/2010 | US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors |
| 07/27/2010 | US7763615 derivatives of ecteinascidins, particularly ecteinascidin 736, used for the treatment of lung, colon, kidney, prostate, cervical, ovarian, breast or pancreatic cancer, leukaemia or melanoma in mammals; reduced systemic toxicity and improved pharmacokinetics |
| 07/27/2010 | US7763606 2,4-benzodiazepine derivatives, used for treating cardiovascular diseases, cognitive and neurodegenerative diseases |
| 07/27/2010 | CA2629339C Pyrazolo[4,3-d]pyrimidin-5-yl) derivative used as pde5 inhibitors |
| 07/27/2010 | CA2518435C Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation |
| 07/27/2010 | CA2481241C Fused quinoxaline derivatives as inhibitors of akt activity |
| 07/27/2010 | CA2449031C Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 07/27/2010 | CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/27/2010 | CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives |
| 07/27/2010 | CA2373797C Methods of treating or preventing affective disorders |
| 07/22/2010 | WO2010083283A2 Processes for preparing jak inhibitors and related intermediate compounds |
| 07/22/2010 | WO2010083264A1 Novel benzenesulfonamides as calcium channel blockers |
| 07/22/2010 | WO2010083141A1 Bicyclic compounds for the reduction of beta-amyloid production |
| 07/22/2010 | WO2010082110A2 Novel process for preparing pure 6-fluoro-3-piperidin-4-yl-1,2-benzisoxazole hydrochloride and its conversion to paliperidone |
| 07/22/2010 | WO2010081788A1 Process for the preparation of n-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-n-methyl-acetamide |
| 07/22/2010 | WO2010047611A9 Process for preparing chlorins and their pharmaceutical uses |
| 07/22/2010 | WO2009137728A3 Method for producing bicyclic guanidines by use of a cyclic urea |
| 07/22/2010 | US20100184970 Porphyrin-based compounds for tumor imaging and photodynamic therapy |
| 07/22/2010 | US20100184771 Bicyclic Heterocyclic Compound |
| 07/22/2010 | US20100184770 Compounds |
| 07/22/2010 | US20100184769 Pde inhibitors for the treatment of hearing impairment |
| 07/22/2010 | US20100184760 Benzoxazole kinase inhibitors and methods of use |
| 07/22/2010 | US20100184754 Quinolinone derivatives |
| 07/22/2010 | US20100184737 Imidazole compounds for the treatment of neurological disorders |
| 07/22/2010 | US20100183604 Preventive/remedy for cancer |
| 07/22/2010 | US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof |
| 07/22/2010 | US20100181555 Material for organic electroluminescent device, organic electroluminescent device, and organic electroluminescent display |
| 07/22/2010 | DE102009005193A1 Neue heterocyclische Verbindungen als MetAP-2 Inhibitoren New heterocyclic compounds as MetAP-2 inhibitors |
| 07/22/2010 | CA2749483A1 Processes for preparing jak inhibitors and related intermediate compounds |
| 07/22/2010 | CA2747752A1 Novel benzenesulfonamides as calcium channel blockers |
| 07/22/2010 | CA2747392A1 Process for the preparation of n-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-n-methyl-acetamide |
| 07/21/2010 | EP2208729A1 Oxazolidinone derivative having 7-membered hetero ring |
| 07/21/2010 | EP1809622B1 Inhibitors of the interaction between mdm2 and p53 |
| 07/21/2010 | CN1964954B Pyrazolo pyrimidines |
| 07/21/2010 | CN101784552A 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 07/21/2010 | CN101784551A bicycloaniline derivative |
| 07/21/2010 | CN101784550A Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 07/21/2010 | CN101784549A Novel macrocyclic inhibitors of hepatitis c virus replication |
| 07/21/2010 | CN101784529A Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors |
| 07/21/2010 | CN101784516A Dipeptide analogs as coagulation factor inhibitors |
| 07/21/2010 | CN101781312A Method for synthesizing derivatives of quinoline or indole |
| 07/21/2010 | CN101781302A Adduct generated from phosphodiesterase inhibitor and isoflavone and application thereof |
| 07/21/2010 | CN101781273A dipeptidylpeptidase iv inhibitor containing guanidyl |
| 07/20/2010 | US7759498 such as 11-(2-dimethylamino-ethyl)-6,11-dihydro-5-thia-11-aza-benzo[a]fluoren-8-ol and 11-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-6,11-dihydro-5-thia-11-aza-benzo [a]fluoren-8-ol; selective estrogen and androgen receptor modulators |
| 07/20/2010 | US7759388 Phenylalanine derivatives |
| 07/20/2010 | US7759383 Small molecule inhibitors of MDM2 and the uses thereof |
| 07/20/2010 | US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor |
| 07/20/2010 | US7759354 Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof |
| 07/20/2010 | US7759349 helminthiasis in animals |
| 07/20/2010 | US7759344 Bis-aryl amide derivatives and methods of use |
| 07/20/2010 | US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 07/20/2010 | US7759337 N-cyclopropyl-4-methyl-3-{1-[(2R)-2-methylpiperazin-1-yl]phthalazin-6-yl}benzamide, useful for the prophylaxis and treatment of protein kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammation disorders |
| 07/20/2010 | CA2486399C Calcium receptor modulating agents |
| 07/20/2010 | CA2428237C Process for the preparation of carbostyril derivatives |
| 07/20/2010 | CA2282906C Stable complexes of poorly soluble compounds |
| 07/15/2010 | WO2010080712A2 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| 07/15/2010 | WO2010078953A1 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd |
| 07/15/2010 | WO2010059602A3 Inhibitors of diacylglycerol acyltransferase |
| 07/15/2010 | US20100179319 Process for production of optically active mirtazapine |
| 07/15/2010 | US20100179189 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 07/15/2010 | US20100179174 Substituted azaquinazolines having an antiviral action |
| 07/15/2010 | US20100179160 Organic compounds |
| 07/15/2010 | US20100179156 Antimicrobial compositions |
| 07/15/2010 | US20100179154 6-CYCLOAMINO-3-(PYRID-4-YL)IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF |
| 07/15/2010 | US20100179127 Pyrimidine derivatives |
| 07/15/2010 | US20100179126 Thiolactams and uses thereof |
| 07/15/2010 | US20100179125 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 07/15/2010 | US20100178291 Pyrrolidinone, Pyrrolidine-2, 5-Dione, Pyrrolidine and Thiosuccinimide Derivatives, Compositions and Methods for Treatment of Cancer |
| 07/15/2010 | US20100178242 Labelling methods |